Detalles de la búsqueda
1.
Quality of life with palbociclib plus fulvestrant versus placebo plus fulvestrant in postmenopausal women with endocrine-sensitive hormone receptor-positive and HER2-negative advanced breast cancer: patient-reported outcomes from the FLIPPER trial.
Ther Adv Med Oncol
; 15: 17588359221148921, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36743520
Resultados
1 -
1
de 1
1
Próxima >
>>